# Project Proposal: Explainable AI-Assisted Diagnostic System for Early Cardiovascular Disease Detection

## 1. Introduction

### 1.1 Context

Cardiovascular diseases (CVDs) are the **leading cause of death worldwide**, claiming approximately 17.9 million lives annually (WHO, 2023). Early and accurate diagnosis is critical for improving patient outcomes, yet current AI models used in clinical settings are often perceived as **"black boxes"**, limiting their adoption by healthcare professionals.

### 1.2 Problem Statement

Despite significant advances in machine learning for medical diagnosis, a critical gap persists between model performance and clinical trust. Physicians require not only accurate predictions but also **transparent, interpretable explanations** to make informed decisions about patient care.

### 1.3 Objective

Develop an **Explainable AI (XAI) system** that:
1. Analyzes multi-modal medical data (ECG signals, cardiac imaging, patient records)
2. Predicts cardiovascular disease risks with high accuracy
3. Provides **clear, actionable explanations** to clinicians
4. Integrates seamlessly into existing clinical workflows

---

## 2. Scope

### 2.1 In Scope
- **Data Types**: Structured clinical data (demographics, lab results), ECG signals, cardiac MRI/CT images
- **Diseases**: Focus on myocardial infarction (MI), arrhythmias, and heart failure
- **XAI Techniques**: SHAP, LIME, Grad-CAM
- **Datasets**: MIMIC-III, PhysioNet/Computing in Cardiology Challenge
- **Deliverables**: Trained models, explainability module, clinical dashboard prototype

### 2.2 Out of Scope
- Real-time deployment in clinical settings (prototype only)
- Regulatory approval (FDA/CE marking)
- Genomic or proteomic data analysis
- Treatment recommendation systems

---

## 3. Methodology

### 3.1 Data Pipeline
1. **Acquisition**: MIMIC-III (structured + waveform data), PhysioNet (ECG signals)
2. **Preprocessing**: Missing value imputation, normalization, feature engineering
3. **Augmentation**: Signal augmentation (time warping, noise injection) for ECG data

### 3.2 Model Architecture
- **Structured Data**: XGBoost / Random Forest with native feature importance
- **ECG Signals**: 1D Convolutional Neural Network (ResNet-based)
- **Cardiac Imaging**: Transfer learning with pre-trained CNNs (ResNet50, EfficientNet)
- **Ensemble**: Late fusion of predictions from individual models

### 3.3 Explainability Framework
| Technique | Data Type | Output |
|-----------|-----------|--------|
| SHAP | Structured data | Feature contribution plots, force plots |
| LIME | Tabular data | Local feature importance rankings |
| Grad-CAM | Medical images | Heatmaps highlighting critical regions |

### 3.4 Evaluation
- **Model Performance**: AUC-ROC, F1-Score, Precision, Recall, Specificity
- **Explainability Quality**: Faithfulness, stability, human-grounded evaluation
- **Clinical Utility**: User studies with cardiologists (questionnaires + think-aloud protocols)

---

## 4. Timeline

| Phase | Duration | Activities |
|-------|----------|------------|
| **Phase 1**: Research & Data | Weeks 1–4 | Literature review, dataset acquisition, IRB approval |
| **Phase 2**: Development | Weeks 5–12 | Data preprocessing, model training, XAI integration |
| **Phase 3**: Evaluation | Weeks 13–16 | Benchmarking, clinical validation studies |
| **Phase 4**: Documentation | Weeks 17–20 | Report writing, paper submission, final presentation |

---

## 5. Resources

### 5.1 Computational
- GPU: NVIDIA A100 / V100 (cloud-based via AWS/GCP)
- Storage: ~500GB for datasets and model checkpoints

### 5.2 Human
- 1 ML Engineer / Researcher (lead)
- 1–2 Clinical collaborators (cardiologists)
- 1 Data annotator (if needed for imaging data)

### 5.3 Datasets
- **MIMIC-III**: Requires PhysioNet credentialed access
- **PhysioNet ECG datasets**: Publicly available
- **Local hospital data**: Requires ethics committee approval

---

## 6. Expected Outcomes

1. **Functional prototype** with >90% AUC-ROC on CVD prediction
2. **Explainability module** producing clinically meaningful explanations
3. **User study results** demonstrating improved physician trust and decision-making
4. **Scientific publication** (target: MICCAI, AIME, or similar venue)

---

## 7. Risks and Mitigation

| Risk | Probability | Impact | Mitigation |
|------|-------------|--------|------------|
| Data access delays (MIMIC-III) | Medium | High | Start with publicly available PhysioNet data |
| Low clinical collaboration | Medium | Medium | Leverage existing academic-clinical partnerships |
| Model performance below threshold | Low | High | Implement ensemble methods, hyperparameter optimization |
| Explainability–accuracy trade-off | Medium | Medium | Use post-hoc methods (SHAP/LIME) to avoid compromising accuracy |

---

## 8. References

1. World Health Organization. (2023). *Cardiovascular Diseases (CVDs) Fact Sheet*.
2. Lundberg, S. M., & Lee, S. I. (2017). *A unified approach to interpreting model predictions*. NeurIPS.
3. Ribeiro, M. T., Singh, S., & Guestrin, C. (2016). *"Why should I trust you?" Explaining the predictions of any classifier*. KDD.
4. Selvaraju, R. R., et al. (2017). *Grad-CAM: Visual explanations from deep networks*. ICCV.
5. Johnson, A. E., et al. (2016). *MIMIC-III, a freely accessible critical care database*. Scientific Data.
